Literature DB >> 867480

Studies into the transplantation biology of ultraviolet light-induced tumors.

R A Daynes, C W Spellman, J G Woodward, D A Stewart.   

Abstract

The majority of skin tumors induced in mice by ultraviolet (UV) light are rejected when implanted into normal syngeneic recipients. Subcarcinogenic levels of UV light exposure render the normally resistant mice susceptible to tumor challenge. The immunoregulatory effect of UV light appears to be additive, since the growth rate of a tumor transplant is dependent upon the length of UV exposure administered prior to implantation. This suppressive influence does not appear to be directly mediated by the UV light, because the amputation of UV-irradiated tail skin allows for a retention of tumor resistance in otherwise tumor-susceptible hosts. UV-irradiated mice could also be immunized against UV tumors, which suggests that immune recognition of tumor-specific transplantation antigens has not been inhibited. The ability of UV exposure to alter normal immunological reactivity to UV-induced tumors is possibly an integral factor in the mechanism underlying UV carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 867480     DOI: 10.1097/00007890-197704000-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Immune responses of diabetic animals. Direct immunosuppressant effects of streptozotocin in mice.

Authors:  W K Nichols; J B Spellman; L L Vann; R A Daynes
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

2.  Impairment of antigen-presenting cell function by ultraviolet radiation.

Authors:  M I Greene; M S Sy; M Kripke; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

3.  Immune surveillance and natural resistance: an evaluation.

Authors:  M L Kripke
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Ultraviolet light-induced suppression of antigen presentation.

Authors:  C W Spellman; T B Tomasi
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

5.  Characterization of variant and parental-cross-protective immunity to immunogenic variants of a murine fibrosarcoma using the local adoptive transfer assay.

Authors:  W Simcik; T L Sheu; S J LeGrue
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Immunological characterization of tumor-rejection antigens on ultraviolet-light-induced tumors originating in the CB6F1 mouse.

Authors:  T Kitajima; M Iwashiro; K Kuribayashi; S Imamura
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

7.  Enhanced tumorigenicity of cloned UV-regressor tumor lines following selected in vivo and in vitro manipulations.

Authors:  M K Schmitt; L K Roberts; L C Gahring; R A Daynes
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

8.  The tumor-rejection antigens of the 1591 ultraviolet fibrosarcoma. Potential origin and evolutionary implications.

Authors:  R Linsk; S Watts; A Fischer; R S Goodenow
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

9.  Heterogeneity of tumorigenicity phenotype in murine tumors. I. Characterization of regressor and progressor clones isolated from a nonmutagenized ultraviolet regressor tumor.

Authors:  M Schmitt; R A Daynes
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

10.  Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation.

Authors:  J L Urban; J M Holland; M L Kripke; H Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.